India, May 26 -- Marksans Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of generic formulations across therapeutic segments. The company has a strong presence in regulated international markets including the US, UK, and Australia, with a diversified product portfolio spanning over-the-counter and prescription medicines.

Marksans Pharma currently has a market capitalization of Rs. 11,388 crore, while the stock trades around Rs. 248 up by 13% compared to its previous close of Rs. 220. The company trades at a P/E ratio of 31.6 and has reported healthy return ratios with ROCE of 20% and ROE of 16.8%. The book value of the company stands at Rs. 59.3 per share.

Marksans Pharma reported revenue from operat...